Logo image of KERN

AKERNA CORP (KERN) Stock Fundamental Analysis

USA - NASDAQ:KERN - US00973W3007 - Common Stock

0.3136 USD
+0.08 (+36.94%)
Last: 2/8/2024, 8:00:03 PM
0.364 USD
+0.05 (+16.07%)
After Hours: 2/8/2024, 8:00:03 PM
Fundamental Rating

0

Overall KERN gets a fundamental rating of 0 out of 10. We evaluated KERN against 281 industry peers in the Software industry. KERN may be in some trouble as it scores bad on both profitability and health. KERN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year KERN has reported negative net income.
KERN had a negative operating cash flow in the past year.
In the past 5 years KERN always reported negative net income.
In the past 5 years KERN always reported negative operating cash flow.
KERN Yearly Net Income VS EBIT VS OCF VS FCFKERN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M

1.2 Ratios

KERN's Return On Assets of -821.29% is on the low side compared to the rest of the industry. KERN is outperformed by 98.92% of its industry peers.
Industry RankSector Rank
ROA -821.29%
ROE N/A
ROIC N/A
ROA(3y)-156.88%
ROA(5y)-120.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KERN Yearly ROA, ROE, ROICKERN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 500 1K 1.5K

1.3 Margins

The Gross Margin of KERN (56.92%) is worse than 61.37% of its industry peers.
KERN's Gross Margin has declined in the last couple of years.
KERN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.77%
GM growth 5Y-4.94%
KERN Yearly Profit, Operating, Gross MarginsKERN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 -200 -400

0

2. Health

2.1 Basic Checks

KERN does not have a ROIC to compare to the WACC, probably because it is not profitable.
KERN has more shares outstanding than it did 1 year ago.
KERN has a worse debt/assets ratio than last year.
KERN Yearly Shares OutstandingKERN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M
KERN Yearly Total Debt VS Total AssetsKERN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

KERN has an Altman-Z score of -66.44. This is a bad value and indicates that KERN is not financially healthy and even has some risk of bankruptcy.
KERN's Altman-Z score of -66.44 is on the low side compared to the rest of the industry. KERN is outperformed by 97.11% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -66.44
ROIC/WACCN/A
WACC3.75%
KERN Yearly LT Debt VS Equity VS FCFKERN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 20M 40M

2.3 Liquidity

A Current Ratio of 0.10 indicates that KERN may have some problems paying its short term obligations.
With a Current ratio value of 0.10, KERN is not doing good in the industry: 98.56% of the companies in the same industry are doing better.
A Quick Ratio of 0.10 indicates that KERN may have some problems paying its short term obligations.
KERN has a worse Quick ratio (0.10) than 98.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
KERN Yearly Current Assets VS Current LiabilitesKERN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.46% over the past year.
Looking at the last year, KERN shows a very negative growth in Revenue. The Revenue has decreased by -31.66% in the last year.
KERN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.51% yearly.
EPS 1Y (TTM)83.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.47%
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y8.05%
Revenue growth 5Y19.51%
Sales Q2Q%-32.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y95.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-57.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KERN Yearly Revenue VS EstimatesKERN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
KERN Yearly EPS VS EstimatesKERN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 -10 -20 -30

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KERN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KERN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KERN Price Earnings VS Forward Price EarningsKERN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KERN Per share dataKERN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

KERN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AKERNA CORP

NASDAQ:KERN (2/8/2024, 8:00:03 PM)

After market: 0.364 +0.05 (+16.07%)

0.3136

+0.08 (+36.94%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2023-11-13/amc
Earnings (Next)03-19 2024-03-19/amc
Inst Owners0.7%
Inst Owner Change0%
Ins Owners40.64%
Ins Owner Change0%
Market Cap3.25M
Revenue(TTM)9.82M
Net Income(TTM)-34.33M
Analysts43.33
Price Target0.82 (161.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.14%
Min EPS beat(2)-59.31%
Max EPS beat(2)27.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.32%
Min Revenue beat(2)-15.72%
Max Revenue beat(2)-14.93%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-37.79
EYN/A
EPS(NY)-1.55
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0.95
BVpS-0.89
TBVpS-1.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -821.29%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.92%
FCFM N/A
ROA(3y)-156.88%
ROA(5y)-120.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.77%
GM growth 5Y-4.94%
F-Score3
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41.04%
Cap/Sales 10.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z -66.44
F-Score3
WACC3.75%
ROIC/WACCN/A
Cap/Depr(3y)132.74%
Cap/Depr(5y)N/A
Cap/Sales(3y)29.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.47%
EPS Next Y95.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y8.05%
Revenue growth 5Y19.51%
Sales Q2Q%-32.03%
Revenue Next Year-57.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.1%
OCF growth 3YN/A
OCF growth 5YN/A

AKERNA CORP / KERN FAQ

Can you provide the ChartMill fundamental rating for AKERNA CORP?

ChartMill assigns a fundamental rating of 0 / 10 to KERN.


Can you provide the valuation status for AKERNA CORP?

ChartMill assigns a valuation rating of 0 / 10 to AKERNA CORP (KERN). This can be considered as Overvalued.


How profitable is AKERNA CORP (KERN) stock?

AKERNA CORP (KERN) has a profitability rating of 0 / 10.


How financially healthy is AKERNA CORP?

The financial health rating of AKERNA CORP (KERN) is 0 / 10.


What is the expected EPS growth for AKERNA CORP (KERN) stock?

The Earnings per Share (EPS) of AKERNA CORP (KERN) is expected to grow by 95.9% in the next year.